Save to folder

Choose Folders Loading...

Podcast Public (all visitors)

CRISPR In China: Cancer Treatment With Gene Editing Underway : NPR

NPR.org 2018

More than a third of patients with cancer of the esophagus responded to experimental treatment in China with the gene-editing technique CRISPR. Several CRISPR studies are underway there.

View Original Source

Curated by

Backpacker-U

Updated 4 days ago

ACADEMIC RESEARCH AI MACHINE LEARNING CANCER GENETICS HEALTHCARE CHINA

Save

Bookmark this resource

Browse more

View all Podcasts

Conversation

Comments

No comments yet. Be the first to comment!

Transcription

Adjacent discoveries

Related resources

Shared chunks

Resources placed near this one.

Electric Buses Are Hurting the Oil Industry - Bloomberg Article • 2018 • Bloomberg.com Appears in 1 shared chunk

Satellite sends quantum-spooky signals to Earth – raising hopes of secure global communications Article • 2018 • The Conversation Appears in 1 shared chunk

E-Commerce Giant JD to Launch Blockchain-as-a-Service Platform - CoinDesk Article • 2018 • CoinDesk Appears in 1 shared chunk

Why Some Platforms Thrive and Others Don’t - Harvard Business Review Article • 2019 • Harvard Business Review Appears in 1 shared chunk

How realistic are China’s plans to colonize the moon? Article • 2019 • The Next Web Appears in 1 shared chunk

Outgrowing Advertising: Multimodal Business Models as a Product Strategy – Andreessen Horowitz Article • 2018 • Andreessen Horowitz Appears in 1 shared chunk

How Idle Heroes made $100M in a Year — Deconstructor of Fun Article • 2019 • Deconstructor of Fun Appears in 1 shared chunk

Chinese subway stations now let you pay for tickets by scanning your face - TNW (2019) Article • 2019 • The Next Web Appears in 1 shared chunk

China Steams Ahead in Gaming; MetaHuman Creator and the Uncanny Valley - 16 Minutes News by a16z Podcast • 2021 • Spotify Appears in 1 shared chunk

A new prosthetic hand | The Economist Article • 2021 • ECONOMIST Appears in 1 shared chunk

China Could Dominate Sodium Batteries, the Next Big Advance in Power - The New York Times Article • 2023 • NYTIMES Appears in 1 shared chunk

China’s startup boom. A new breed of unicorn. How to make it big in Xi Jinping’s China Article • 2023 • The Economist Appears in 1 shared chunk

Shared categories

Resources with similar topic signals.

Mexico is phasing out imports of glyphosate and GMO corn. Impact on U.S. trade Article • 2021 • THECOUNTER Shares 1 topic signal

Covid-19: why travel will never be the same | The Economist Video • 2020 • Youtube - The Economist Shares 1 topic signal

Almost Everywhere, Fewer Children Are Dying - The New York Times Article • 2019 • NYTIMES Shares 1 topic signal

Child mortality is an everyday tragedy of enormous scale that rarely makes the headlines Article • 2019 • Our World in Data Shares 1 topic signal

Banned bread: why does the US allow additives that Europe says are unsafe? | US news | The Guardian Article • 2019 • the Guardian Shares 1 topic signal

How Africa is seizing an AI opportunity - Fast Company Article • 2019 • Fast Company Shares 1 topic signal

The short history of global living conditions and why it matters that we know it - Our World in Data Article • 2019 • Our World in Data Shares 1 topic signal

U.S. Health Care Spending Highest Among Developed Countries - 2018 - Johns Hopkins University Article • 2019 • Johns Hopkins Bloomberg School of Public Health Shares 1 topic signal

How Waymo Made Chandler, Arizona the Self-Driving Capital of the World | WIRED Article • 2018 • WIRED Shares 1 topic signal

Goal 3: Ensure healthy lives and promote well-being for all at all ages Article • 2018 • United Nations Sustainable Development Shares 1 topic signal

Some good news, for once | Bill Gates Article • 2018 • gatesnotes.com Shares 1 topic signal

Shopping for Health Care Simply Doesn’t Work. So What Might? - The New York Times Article • 2018 • NYTIMES Shares 1 topic signal

CRISPR In China: Cancer Treatment With Gene Editing Underway : NPR

Backpacker-U

Related resources

More from source

Found something worth adding?